That reputation is true as far as its goes. But, in spite of the emphasis on pure science, Yeda Research and Development, Weizmann’s technology transfer arm, has had great success in its efforts to ...

REHOVOT, Israel--(BUSINESS WIRE)--flō has signed an exclusive license agreement with Yeda Research and Development Co., Ltd. regarding the use of Weizmann Advanced Materials used for optical ...

DURHAM, N.C., Nov. 17, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies ...

About Yeda Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda currently manages approximately 500 unique patent families and has generated ...

An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science ... license for the solar technology from Yeda, the Weizmann Institute's technology transfer ...

The program is being carried out in partnership with Yeda Research and Development Company, Weizmann's technology transfer arm. More information: Sabita Chourasia et al, MTCH2 controls energy ...

"We are happy to collaborate with the Weizmann Institute of Science, through its commercial arm, Yeda, on Myeloid research using Sequentify's Myeloid panel for the research of CKD and cognitive ...

Abbott Laboratories will fund research programs in select areas of medicine through Yeda Research and Development Company, the technology transfer arm of the world-renowned Weizmann Institute of ...

Last year, Yeda Research and Development, the tech transfer office of the Weizmann Institute, sued ImClone and Sanofi-Aventis over the Erbitux patent. (The patent was owned by the latter and licensed ...